FI965008A0 - Koostumukset ja menetelmät kasvainten hoitamiseksi - Google Patents

Koostumukset ja menetelmät kasvainten hoitamiseksi

Info

Publication number
FI965008A0
FI965008A0 FI965008A FI965008A FI965008A0 FI 965008 A0 FI965008 A0 FI 965008A0 FI 965008 A FI965008 A FI 965008A FI 965008 A FI965008 A FI 965008A FI 965008 A0 FI965008 A0 FI 965008A0
Authority
FI
Finland
Prior art keywords
compositions
methods
treating tumors
tumors
treating
Prior art date
Application number
FI965008A
Other languages
English (en)
Swedish (sv)
Other versions
FI965008A (fi
FI119677B (fi
Inventor
Gordon A Vehar
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of FI965008A publication Critical patent/FI965008A/fi
Publication of FI965008A0 publication Critical patent/FI965008A0/fi
Application granted granted Critical
Publication of FI119677B publication Critical patent/FI119677B/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4833—Thrombin (3.4.21.5)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
    • A61K39/3955—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against proteinaceous materials, e.g. enzymes, hormones, lymphokines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Endocrinology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
FI965008A 1994-06-16 1996-12-13 Prokoagulantin ja sytokiinin käyttö FI119677B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US26085094A 1994-06-16 1994-06-16
US26085094 1994-06-16
PCT/US1995/007305 WO1995034319A1 (en) 1994-06-16 1995-06-08 Compositions and methods for the treatment of tumors
US9507305 1995-06-08

Publications (3)

Publication Number Publication Date
FI965008A FI965008A (fi) 1996-12-13
FI965008A0 true FI965008A0 (fi) 1996-12-13
FI119677B FI119677B (fi) 2009-02-13

Family

ID=22990887

Family Applications (1)

Application Number Title Priority Date Filing Date
FI965008A FI119677B (fi) 1994-06-16 1996-12-13 Prokoagulantin ja sytokiinin käyttö

Country Status (11)

Country Link
US (2) US5830448A (fi)
EP (1) EP0765168B1 (fi)
JP (1) JPH10501813A (fi)
KR (1) KR970703783A (fi)
AU (1) AU696003B2 (fi)
CA (1) CA2191065A1 (fi)
DE (1) DE69524093T2 (fi)
FI (1) FI119677B (fi)
IL (1) IL114119A (fi)
WO (1) WO1995034319A1 (fi)
ZA (1) ZA954984B (fi)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5965132A (en) * 1992-03-05 1999-10-12 Board Of Regents, The University Of Texas System Methods and compositions for targeting the vasculature of solid tumors
US6749853B1 (en) * 1992-03-05 2004-06-15 Board Of Regents, The University Of Texas System Combined methods and compositions for coagulation and tumor treatment
US6132730A (en) 1997-01-22 2000-10-17 Board Of Regents, The University Of Texas System Combined tissue factor and factor VIIa methods and compositions for coagulation and tumor treatment
WO1999040929A1 (en) * 1998-02-12 1999-08-19 The General Hospital Corporation Methods to potentiate cancer therapies
US6719977B1 (en) 1998-02-12 2004-04-13 The General Hospital Corporation Methods to potentiate cancer therapies
ATE355029T1 (de) * 1998-04-01 2006-03-15 Univ Columbia Verfahren zur thrombosehemmung bei patienten deren blut extrakorporaler zirkulation ausgesetzt ist
US6818213B1 (en) * 1998-07-13 2004-11-16 Board Of Regents, The University Of Texas System Cancer treatment compositions comprising therapeutic conjugates that bind to aminophospholipids
PT1520588E (pt) * 1998-07-13 2015-03-31 Univ Texas Usos de anticorpos para amino fosfolípidos para o tratamento do cancro
AU750414B2 (en) * 1998-07-13 2002-07-18 Board Of Regents, The University Of Texas System Cancer treatment methods using therapeutic conjugates that bind to aminophospholipids
US6406693B1 (en) 1998-07-13 2002-06-18 Board Of Regents, The University Of Texas System Cancer treatment methods using antibodies to aminophospholipids
US20030124132A1 (en) * 2001-09-27 2003-07-03 Board Of Regents, The University Of Texas System Combined compositions for tumor vasculature coaguligand treatment
CA2460341A1 (en) * 2001-10-05 2003-04-17 Intermune, Inc. Methods of treating liver fibrosis and hepatitis c virus infection
CA2587143C (en) * 2004-12-08 2017-12-05 Immunomedics, Inc. Methods and compositions for immunotherapy and detection of inflammatory and immune-dysregulatory disease, infectious disease, pathologic angiogenesis and cancer
WO2012160031A1 (en) 2011-05-24 2012-11-29 Institut National De La Sante Et De La Recherche Medicale (Inserm) Method for prognosing solid tumor outcome
US10575774B2 (en) * 2017-02-27 2020-03-03 Case Western Reserve University Predicting immunotherapy response in non-small cell lung cancer with serial radiomics

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4506009A (en) * 1982-03-30 1985-03-19 University Of California Heterogeneous immunoassay method
AU630106B2 (en) * 1988-07-15 1992-10-22 Trustees Of Columbia University In The City Of New York, The Tumor necrosis enhancing factor and methods of preparation and use
US5147638A (en) * 1988-12-30 1992-09-15 Oklahoma Medical Research Foundation Inhibition of tumor growth by blockade of the protein C system
AU646633B2 (en) * 1989-02-17 1994-03-03 Codon Soluble analogs of thrombomodulin
US5196404B1 (en) * 1989-08-18 1996-09-10 Biogen Inc Inhibitors of thrombin
CA2452130A1 (en) * 1992-03-05 1993-09-16 Francis J. Burrows Methods and compositions for targeting the vasculature of solid tumors
FR2695562B1 (fr) * 1992-09-11 1994-10-14 Synthelabo Utilisation d'un inhibiteur direct de la thrombine pour la fabrication d'un médicament à activité thrombolytique.

Also Published As

Publication number Publication date
EP0765168B1 (en) 2001-11-21
FI965008A (fi) 1996-12-13
IL114119A0 (en) 1995-10-31
KR970703783A (ko) 1997-08-09
CA2191065A1 (en) 1995-12-21
WO1995034319A1 (en) 1995-12-21
EP0765168A1 (en) 1997-04-02
FI119677B (fi) 2009-02-13
JPH10501813A (ja) 1998-02-17
IL114119A (en) 2000-09-28
US5830448A (en) 1998-11-03
AU2821295A (en) 1996-01-05
US5762921A (en) 1998-06-09
ZA954984B (en) 1996-12-17
AU696003B2 (en) 1998-08-27
DE69524093D1 (de) 2002-01-03
DE69524093T2 (de) 2002-07-11

Similar Documents

Publication Publication Date Title
FI970918A (fi) Yhdisteet ja menetelmät syövän hoitamiseksi
NO20003096L (no) Sammensetninger og fremgangsmÕter for behandling av ADD
FI971969A0 (fi) Peräpukamien hoitoon tarkoitettuja koostumuksia ja käyttömenetelmä
EE03399B1 (et) Teraapias kasutatavad spiro-asabitsüklilised ühendid ja nende valmistamise protsess
NO984431L (no) FremgangsmÕte for behandling av smerte
DE69518919D1 (de) Autoantikörper enthaltende zusammensetzung für tumorbehandlung und -vorbeugung
DE69526966D1 (de) Hautkräftigende kometische zusammensetzung
GR3036364T3 (en) Compositions and methods for treating or preventing inflammatory diseases
DE69812603D1 (de) Substituierte benzopyranderivate zur behandlung von entzündungen
DE69513916D1 (de) Oberflächenbehandlungszusammensetzung
EP0709090A3 (en) Compositions for the treatment of resistant tumors
DE69603089D1 (de) Zusammensetzung zur behandlung von mauerwerk
EP0758196A4 (en) COMPOSITIONS AND METHODS FOR TREATING TUMORS
FI954773A (fi) Antihypertriglyserideeminen koostumus
FI965008A (fi) Koostumukset ja menetelmät kasvainten hoitamiseksi
DE69520998D1 (de) Faserbehandlungszusammensetzungen
BR9510062A (pt) Macromonômeto esterificado e composição
NO984446D0 (no) FremgangsmÕte for behandling av smerte
FI971138A (fi) Keraamisia eristeitä ja menetelmiä niiden muodostamiseksi
FI954245A (fi) Koostumuksia ja menetelmiä immunovälitteisten tulehduksellisten häiriöiden hoitamiseksi
ATE209195T1 (de) Naphthylverbindungen und zusammensetzungen
BR9505995A (pt) Composto método para tratamentos e composição farmacêutica
ITMI940362A0 (it) Composizione antitosse
NO964485D0 (no) Fremgangsmåte for stabilisering av forbindelsen DX-52-1 og lyofilisert sammensetning derav
FI955123A (fi) Kolestyramiinia sisältävä koostumus ja menetelmä tämän valmistamiseksi

Legal Events

Date Code Title Description
FG Patent granted

Ref document number: 119677

Country of ref document: FI

MA Patent expired